Matchpoint Therapeutics Overview
- Year Founded
-
2021

- Status
-
Private
- Employees
-
33

- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$70M
- Investors
-
7
Matchpoint Therapeutics General Information
Description
Developer of precision small molecule medicines intended to harness the power of covalency to transform the treatment of immune diseases. The company's advanced covalent exploration platform integrates advanced chemo proteomics, machine learning, and covalent chemistry library evolution, enabling medical professionals to probe deeper into the proteome to identify and scan new binding sites on disease-causing proteins.
Contact Information
Website
www.matchpointtx.comCorporate Office
- One Kendall Square
- Building 400 Suite 201
- Cambridge, MA 02139
- United States
Corporate Office
- One Kendall Square
- Building 400 Suite 201
- Cambridge, MA 02139
- United States
Matchpoint Therapeutics Timeline
Matchpoint Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Early Stage VC (Series A) | 14-Oct-2022 | $70M | Completed | Generating Revenue | ||
1. Seed Round | 01-Nov-2021 | Completed | Generating Revenue |
Matchpoint Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | ||||||||
Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Matchpoint Therapeutics Signals
Matchpoint Therapeutics Investors (7)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Alexandria Venture Investments | Venture Capital | Minority | ||
Digitalis Ventures | Venture Capital | Minority | ||
Sanofi Ventures | Corporate Venture Capital | Minority | ||
Vertex Ventures HC | Venture Capital | Minority | ||
Access Biotechnology | Corporate Venture Capital | Minority |
Matchpoint Therapeutics FAQs
-
When was Matchpoint Therapeutics founded?
Matchpoint Therapeutics was founded in 2021.
-
Where is Matchpoint Therapeutics headquartered?
Matchpoint Therapeutics is headquartered in Cambridge, MA.
-
What is the size of Matchpoint Therapeutics?
Matchpoint Therapeutics has 33 total employees.
-
What industry is Matchpoint Therapeutics in?
Matchpoint Therapeutics’s primary industry is Drug Discovery.
-
Is Matchpoint Therapeutics a private or public company?
Matchpoint Therapeutics is a Private company.
-
What is the current valuation of Matchpoint Therapeutics?
The current valuation of Matchpoint Therapeutics is
. -
What is Matchpoint Therapeutics’s current revenue?
The current revenue for Matchpoint Therapeutics is
. -
How much funding has Matchpoint Therapeutics raised over time?
Matchpoint Therapeutics has raised $100M.
-
Who are Matchpoint Therapeutics’s investors?
Alexandria Venture Investments, Digitalis Ventures, Sanofi Ventures, Vertex Ventures HC, and Access Biotechnology are 5 of 7 investors who have invested in Matchpoint Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »